Skip to main content
Fig. 2 | Journal of Neuroinflammation

Fig. 2

From: A co-ultramicronized palmitoylethanolamide/luteolin composite mitigates clinical score and disease-relevant molecular markers in a mouse model of experimental autoimmune encephalomyelitis

Fig. 2

Effect of PEALut treatment, started at 2 PID, on neurologic score severity in MOG35-55 immunized mice. All mice were immunized with MOG35-55 and treated with PEALut at 5 mg/kg or corresponding Veh starting at 2 PID. Data are presented as means ± SD. n = 8 for each experimental group. The PEALut treatment induced a significant reduction in score severity (p = 0.04, repeated measure ANOVA)

Back to article page

Journal of Neuroinflammation

ISSN: 1742-2094